French drug maker Sanofi SA said Wednesday it will eliminate about 100 in Massachusetts, mainly in research and development.
The jobs, most of them in Cambridge, include 30 at a small cancer research unit being folded into Sanofi’s broader research organization. The rest are at the Sanofi Genzyme Research and Development Center, which focuses primarily on rare diseases.
Sanofi’s move is part of an ongoing “reprioritization of our early-stage research platforms,” said Jack Cox, a spokesman at Sanofi headquarters in Paris. Sanofi paid $20.1 billion to acquire Cambridge-based Genzyme in 2011.
The company has about 5,000 employees in Cambridge and Framingham and 110,000 worldwide.
“In the general scheme of this, it’s some continual realignment,” Cox said. “In no way is Sanofi changing its commitment to Massachusetts or the Boston area.”